Articles
Exelon 2 mg/ml, Lösung zum Einnehmen

Exelon 2 mg/ml, Lösung zum Einnehmen

7680550510025 CH-55051 Lösung

Associated product:

EXELON sol 2 mg/ml fl 120 ml

1 / 3

google

Article details

Package size: 120
Selling units: 120
Measure: ml
Galenic form: Lösung
Galenic group: unbekannt

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance	Quantity	Type	Category
rivastigminum	2.0 MG	Substance	Wirkstoff (Principe actif)
rivastigmini hydrogenotartras	-	Substance	WIZUS
acidum citricum	-	Substance	HNIDK
natrii citras dihydricus	-	Substance	HNIDK
E 104	-	Substance	FIMDK
E 211	1.0 MG	Substance	HBESI
aqua purificata	-	Substance	HNIDK
natrium	1.82 MG	Substance	HBESI

Reimbursement information

Public price

CHF 84.25

Specialties list

Yes

Generic

Reimbursement limitation

SL addition date: 01/01/2000

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number: 55051
Drug name: Exelon 2 mg/ml, Lösung zum Einnehmen
Galenic form: LSOR
ATC Code: N06DA03
Authorization status: Z
Dispensing category: B
First authorization: 04/06/1999
Authorization expiration date: 31/12/9999
IT Number: 01.99.0.
Domain: Human medicine

Field of application

Demenz vom Alzheimer Typ, Demenz bei Parkinson Krankheit

Package details

Description (FR): EXELON sol 2 mg/ml fl 120 ml
Description (DE): EXELON Lös 2 mg/ml Fl 120 ml
Market launch: 04/06/1999
Narcotic (BTM): No

Available generics (10)

Rivastigmin-Mepha Patch, Transdermale Pflaster

GTIN: 7680687950015

CHF 54.05

View

Rivastigmin-Mepha Patch, Transdermale Pflaster

GTIN: 7680687950022

CHF 54.05

View

Rivastigmin-Mepha Patch, Transdermale Pflaster

GTIN: 7680687950039

CHF 91.70

View

Rivastigmin-Mepha Patch, Transdermale Pflaster

GTIN: 7680687950046

CHF 54.05

View

Rivastigmin-Mepha Patch, Transdermale Pflaster

GTIN: 7680687950053

CHF 91.70

View